Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
SRTSW was delisted on the 4th of June, 2020.
4 hedge funds and large institutions have $725K invested in Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
39% more capital invested
Capital invested by funds: $523K → $725K (+$202K)
20% less funds holding
Funds holding: 5 → 4 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$97 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
-$163K |
SRTSW Hedge Fund Activity: Q2 2018 in Review
4 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 (SRTSW) for Q2 2018, worth a combined $725K — up 39% from $523K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SRTSW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $97. The largest seller was Highbridge Capital Management, exiting entirely with an estimated $163K sold.
- 4 institutional investors held Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 (SRTSW) as of Q2 2018, down from 5 in Q1 2018.
- Funds reported $725K of Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 stock for Q2 2018, up 39% quarter-over-quarter.
- 0 funds opened new Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 positions in Q2 2018 and 1 closed out, a net change of -1 holder.
- The largest Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 buyer in Q2 2018 was UBS Group, an estimated $97 added.
- The largest Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 seller in Q2 2018 was Highbridge Capital Management, an estimated $163K sold.
Based on aggregated 13F filings for Q2 2018.